The Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Men with Low-risk Prostate Cancer: A Cost-effectiveness Modeling Study

Torre, 2016, Global cancer incidence and mortality rates and trends—an update, Cancer Epidemiol Biomarkers Prev, 25, 16, 10.1158/1055-9965.EPI-15-0578 Dall’Era, 2012, Active surveillance for prostate cancer: a systematic review of the literature, Eur Urol, 62, 976, 10.1016/j.eururo.2012.05.072 Wallis, 2018, Survival and complications following surgery and radiation for localized prostate cancer: an international collaborative review, Eur Urol, 73, 11, 10.1016/j.eururo.2017.05.055 European Association of Urology. Prostate cancer guidelines. http://uroweb.org/guideline/prostate-cancer/. Loeb, 2013, Systematic review of complications of prostate biopsy, Eur Urol, 64, 876, 10.1016/j.eururo.2013.05.049 Corcoran, 2012, Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours, BJU Int, 109, 660, 10.1111/j.1464-410X.2011.10543.x Hu, 2012, A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomy, BJU Int, 110, 812, 10.1111/j.1464-410X.2012.10933.x Tosoian, 2016, Active surveillance for prostate cancer: current evidence and contemporary state of practice, Nat Rev Urology, 13, 205, 10.1038/nrurol.2016.45 Johnson, 2017, Multi-parametric magnetic resonance imaging as a management decision tool, Transl Androl Urol, 6, 472, 10.21037/tau.2017.05.22 Futterer, 2015, Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging?. A systematic review of the literature, Eur Urol, 68, 1045, 10.1016/j.eururo.2015.01.013 Schoots, 2015, Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis, Eur Urol, 68, 438, 10.1016/j.eururo.2014.11.037 Walton Diaz, 2015, Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance, Urol Oncol, 33, 10.1016/j.urolonc.2015.01.023 Prostate Cancer Research International: Active Surveillance. Guideline and study for the expectant management of localized prostate cancer with curative intent. 2014. www.prias-project.org/uploads/pdfs/2014-11-27%20Protocol%20versie%205.0%20(FINAL).pdf. Zorginstituut Nederland, 2016 Bill-Axelson, 2014, Radical prostatectomy or watchful waiting in early prostate cancer, N Engl J Med, 370, 932, 10.1056/NEJMoa1311593 Heijnsdijk, 2012, Quality-of-life effects of prostate-specific antigen screening, New Engl J Med, 367, 595, 10.1056/NEJMoa1201637 Stewart, 2005, Utilities for prostate cancer health states in men aged 60 and older, Med Care, 43, 347, 10.1097/01.mlr.0000156862.33341.45 de Rooij, 2014, Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis, Am J Roentgenol, 202, 343, 10.2214/AJR.13.11046 Mowatt, 2013, The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation, Health Technol Assess, 17, 1, 10.3310/hta17200 de Rooij, 2014, Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective, Eur Urol, 66, 430, 10.1016/j.eururo.2013.12.012 Hayes, 2013, Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis, Ann Intern Med, 158, 853, 10.7326/0003-4819-158-12-201306180-00002 Thomsen, 2014, Active surveillance for clinically localized prostate cancer—a systematic review, J Surg Oncol, 109, 830, 10.1002/jso.23584 Netherlands Comprehensive Cancer Organisation, 2014 Statistics Netherlands, 2016 Bokhorst, 2016, A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment, Eur Urol, 70, 954, 10.1016/j.eururo.2016.06.007 Loeb, 2012, Infectious complications and hospital admissions after prostate biopsy in a European randomized trial, Eur Urol, 61, 1110, 10.1016/j.eururo.2011.12.058 Heijnsdijk, 2009, Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer, Br J Cancer, 101, 1833, 10.1038/sj.bjc.6605422 Ahmed, 2017, Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study, Lancet, 389, 815, 10.1016/S0140-6736(16)32401-1 Pahwa, 2017, Cost-effectiveness of MR imaging-guided strategies for detection of prostate cancer in biopsy-naive men, Radiology, 285, 157, 10.1148/radiol.2017162181 Gordon, 2017, Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia, J Magn Reson Imaging, 45, 1304, 10.1002/jmri.25504 Faria, 2018, Optimising the diagnosis of prostate cancer in the era of multiparametric magnetic resonance imaging: a cost-effectiveness analysis based on the Prostate MR Imaging Study (PROMIS), Eur Urol, 73, 23, 10.1016/j.eururo.2017.08.018